stemcellonline.info

Govt to fund iPS cell studyThe Daily Yomiuri, Japan - Dec 20, 2007A team led by Shinya Yamanaka, a professor at Kyoto University, was the first in the world to develop iPS cells, a type of pluripotent stem cell that can …

Canada.com

Human Embryonic Stem Cell Lines Created That Avoid Immune RejectionScience Daily (press release) - Dec 20, 200720, 2007) — In a groundbreaking experiment scientists from International Stem Cell (ISC) Corp. derived four unique embryonic stem cell lines that open the …"Virgin" birth stem cells may offer tissue bank ReutersInternational Stem Cell Corporation Creates Human Stem Cell [...]

Athersys and Angiotech announce authorization of stem cell …The Canadian Press - Dec 20, 2007The two companies signed an agreement in May 2006 to co-develop and commercialize MultiStem, Athersys' non-embryonic stem cell platform technology. …Athersys and Angiotech announce authorization of Phase I … CNNMoney.comAthersys, Angiotech Pharma Reveal Authorization Of Phase I … Trading Markets (press release)Athersys [...]

Stem-cell firms resisting cash lureSan Jose Mercury News,  USA - Dec 20, 2007By Steve Johnson Persuading the private sector to accept a handout from California's $3 billion stem-cell institute might strike some as a no-brainer. …INSTITUTE'S OFFER TO BUSINESSES San Jose Mercury Newsall 9 news articles

Altered role for stem cell regulatorScientist, UK - Dec 19, 2007In a recent paper on reprogramming human somatic cells into embryonic stem cell-like cells by James Thomson's group at the University of Wisconsin, Madison, …Stem cells go to the movies Nature.com (subscription)Dimmer switch idea casts new light on illness Scotsmanall 5 news articles

“If this is real, it could have almost immediate impact”
Cancerous stem cells are the focus of a preliminary study that will be launched within the next few months by scientists at three U.S. medical centers: the University of Michigan Comprehensive Cancer Center, … via HealthDay

Govt to fund iPS cell studyThe Daily Yomiuri, Japan - Dec 20, 2007A team led by Shinya Yamanaka, a professor at Kyoto University, was the first in the world to develop iPS cells, a type of pluripotent stem cell that can …

Canada.com

Human Embryonic Stem Cell Lines Created That Avoid Immune RejectionScience Daily (press release) - Dec 20, 200720, 2007) — In a groundbreaking experiment scientists from International Stem Cell (ISC) Corp. derived four unique embryonic stem cell lines that open the …"Virgin" birth stem cells may offer tissue bank ReutersInternational Stem Cell Corporation Creates Human Stem Cell [...]

Athersys and Angiotech announce authorization of stem cell …The Canadian Press - Dec 20, 2007The two companies signed an agreement in May 2006 to co-develop and commercialize MultiStem, Athersys' non-embryonic stem cell platform technology. …Athersys and Angiotech announce authorization of Phase I … CNNMoney.comAthersys, Angiotech Pharma Reveal Authorization Of Phase I … Trading Markets (press release)Athersys [...]

Stem-cell firms resisting cash lureSan Jose Mercury News,  USA - Dec 20, 2007By Steve Johnson Persuading the private sector to accept a handout from California's $3 billion stem-cell institute might strike some as a no-brainer. …INSTITUTE'S OFFER TO BUSINESSES San Jose Mercury Newsall 9 news articles